http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NZ-544066-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1bcb11020d8e5c2262cbdfb4f1200e0a |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S530-825 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0808 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0821 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K11-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-083 |
| filingDate | 2004-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4912258b2b1fbd40489f8dc502389a6a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6cb6f80c3679416e1cf5b62fe737f816 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f53143b123a2f36b0885b24a02f99a7e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb5d06f4b94b8170eca6dcbb60f43ab1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1e65f2c7de98bcb0fec5a4d20a277c3 |
| publicationDate | 2008-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | NZ-544066-A |
| titleOfInvention | New cytotoxic depsipeptides |
| abstract | Disclosed is a compound of general formula (I) wherein R1 are each independently selected from the group consisting of hydrogen, halogen, cyano, hydroxyl, nitro, azido, substituted or unsubstituted alkyl, substituted or unsubstituted alkyldiene, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, substituted or unsubstituted alkoxy, substituted or unsubstituted aryl, substituted or unsubstituted heterocyclic group and substituted or unsubstituted acyl; R3 groups are independently selected from the group consisting of hydrogen, halogen, cyano, hydroxyl, nitro, azido, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, substituted or unsubstituted alkoxy, substituted or unsubstituted aryl, substituted or unsubstituted heterocyclic group and substituted or unsubstituted acyl; R4 groups are each independently selected from NR2, O and S; and R2 groups are each independently selected from the group consisting of hydrogen, substituted or unsubstituted alkyl, substituted or unsubstituted aryl, substituted or unsubstituted alkoxy and substituted or unsubstituted acyl, or a pharmaceutically acceptable salt or stereoisomer thereof. Also disclosed is the use of the above compound, or a pharmaceutically acceptable salt or stereoisomer thereof, in the preparation of a medicament for the treatment of cancer. |
| priorityDate | 2003-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 87.